Analyst Ims Investment Management Services Ltd. Gilead Sciences, Inc. Transaction History

Analyst Ims Investment Management Services Ltd.

$2.44 Billion
Q2 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $404,567 - $453,675	-6,539 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $536,989 - $700,730	-8,870 Reduced 57.56%	6,539 $409,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $288,327 - $319,231	-4,045 Reduced 20.79%	15,409 $1.18 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $145,857 - $171,216	-2,050 Reduced 9.53%	19,454 $1.39 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $7,211 - $8,547	-100 Reduced 0.46%	21,504 $1.74 Million
Q2 2017 Aug 07, 2017	BUY	N/A	21,604	21,604 $1.53 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.64 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.38 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.05 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.96 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Analyst Ims Investment Management Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Analyst Ims Investment Management Services Ltd. with notifications on news.

Account